The field of genomics is revolutionizing cancer treatment by enabling personalized medicine. By sequencing the genomes of cancer cells, scientists can identify specific mutations driving the disease. This information allows for the development of targeted therapies, such as PARP inhibitors for BRCA-mutated cancers. Recent studies have also explored the potential of CRISPR-Cas9 to edit genetic mutations directly.
